Spoken Alpha
DBVT
DBV Technologies S.A.
Overview
DBV Technologies S.A is a Healthcare company operating in Biotechnology with a $963.2M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $-0.12—Rev— vs ——EODHD
- Q1 FY20262026-04-30EPS$-0.09 vs $-0.12+22.5%Rev$0 vs ——EODHD
- Q4 FY20252026-03-26EPS$-0.20 vs $-0.19-5.7%Rev$0 vs ——EODHD
- Q3 FY20252025-10-27EPS$-0.24 vs $-0.29+17.7%Rev$0 vs ——EODHD
- Q2 FY20252025-07-28EPS$-0.31 vs $-0.16-97.8%Rev$0 vs ——EODHD
- Q1 FY20252025-04-10EPS$-0.23 vs $-0.23-1.5%Rev$511.0K vs ——EODHD
- Q4 FY20242025-03-04EPS$-0.21 vs $-0.21-1.2%Rev$0 vs ——EODHD
- Q3 FY20242024-11-06EPS$-1.49 vs $-1.64+9.2%Rev$1.1M vs ——EODHD
- Q2 FY20242024-07-29EPS$-0.34 vs $-0.45+24.4%Rev$1.2M vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.56 vs $-0.21-100.0%Rev$1.4M vs ——EODHD
- Q4 FY20232024-03-06EPS$-0.06 vs $-0.23+74.7%Rev$8.9M vs ——EODHD
- Q3 FY20232023-10-30EPS$-0.08 vs $-0.22+63.6%Rev$2.4M vs ——EODHD
- Q2 FY20232023-07-30EPS$-0.12 vs $-0.19+36.8%Rev$2.3M vs ——EODHD
- Q1 FY20232023-05-03EPS$-0.22 vs $-0.21-6.4%Rev$2.2M vs ——EODHD
- Q4 FY20222023-03-01EPS$-0.44 vs $-0.17-100.0%Rev$-1.3M vs ——EODHD
- Q3 FY20222022-11-02EPS$-0.18 vs $-0.32+43.8%Rev$2.1M vs ——EODHD
- Q2 FY20222022-07-31EPS$-0.33 vs $-0.31-6.5%Rev$1.5M vs ——EODHD
- Q1 FY20222022-05-01EPS$-0.27 vs $-0.39+30.8%Rev$2.5M vs ——EODHD
- Q4 FY20212022-03-02EPS$-0.11 vs $-0.49+77.5%Rev$2.9M vs ——EODHD
- Q3 FY20212021-10-25EPS$-0.19 vs $-0.43+55.8%Rev$1.3M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $-0.12 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-04-30 | $-0.09 | $-0.12 | +22.5% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-26 | $-0.20 | $-0.19 | -5.7% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-10-27 | $-0.24 | $-0.29 | +17.7% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-07-28 | $-0.31 | $-0.16 | -97.8% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-04-10 | $-0.23 | $-0.23 | -1.5% | $511.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-04 | $-0.21 | $-0.21 | -1.2% | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-1.49 | $-1.64 | +9.2% | $1.1M | — | — | EODHD |
| Q2 FY2024 | 2024-07-29 | $-0.34 | $-0.45 | +24.4% | $1.2M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.56 | $-0.21 | -100.0% | $1.4M | — | — | EODHD |
| Q4 FY2023 | 2024-03-06 | $-0.06 | $-0.23 | +74.7% | $8.9M | — | — | EODHD |
| Q3 FY2023 | 2023-10-30 | $-0.08 | $-0.22 | +63.6% | $2.4M | — | — | EODHD |
| Q2 FY2023 | 2023-07-30 | $-0.12 | $-0.19 | +36.8% | $2.3M | — | — | EODHD |
| Q1 FY2023 | 2023-05-03 | $-0.22 | $-0.21 | -6.4% | $2.2M | — | — | EODHD |
| Q4 FY2022 | 2023-03-01 | $-0.44 | $-0.17 | -100.0% | $-1.3M | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $-0.18 | $-0.32 | +43.8% | $2.1M | — | — | EODHD |
| Q2 FY2022 | 2022-07-31 | $-0.33 | $-0.31 | -6.5% | $1.5M | — | — | EODHD |
| Q1 FY2022 | 2022-05-01 | $-0.27 | $-0.39 | +30.8% | $2.5M | — | — | EODHD |
| Q4 FY2021 | 2022-03-02 | $-0.11 | $-0.49 | +77.5% | $2.9M | — | — | EODHD |
| Q3 FY2021 | 2021-10-25 | $-0.19 | $-0.43 | +55.8% | $1.3M | — | — | EODHD |
Source: EODHD. DBVT reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks DBVT's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 3 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.65 | $0.65 | +0.4% | -0.5% | +2.5% |
| Q4 FY2026 | $0.72 | $0.67 | +6.8% | -2.4% | -4.4% |
| Q3 FY2026 | $0.81 | $0.73 | +10.9% | +1.7% | +2.2% |
| Q2 FY2026 | $0.88 | $0.88 | +0.2% | +2.0% | +2.7% |
| Q1 FY2025 | $0.72 | $0.71 | +1.6% | -5.1% | -6.5% |
| Q4 FY2025 | $1.03 | $0.94 | +9.6% | -0.6% | +0.2% |
| Q3 FY2025 | $0.86 | $0.81 | +6.0% | -0.2% | -2.7% |
| Q2 FY2025 | $0.94 | $0.87 | +8.6% | -7.6% | -6.0% |
| Q1 FY2024 | $1.02 | $0.98 | +4.3% | -9.1% | -10.4% |
| Q4 FY2024 | $0.87 | $0.78 | +12.0% | -1.3% | -0.1% |
Guidance change history
Sample- Q1 FY2026Maintained2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Maintained2026-07-15
- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Daniel TasseCEO2 yr 3 mo10 callsCurrentSample
CEO since 2024 • 3/8 beats (38%) • guidance suspended Q2 FY2026
- Virginie BoucinhaCFO2 yr 7 mo2 callsCurrentSample
CFO since 2023 • 8/12 beats (67%) • last call held guidance Q1 FY2026
- Kevin Michael TrappChief Commercial Officer7 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance cut Q1 FY2026
- Pharis MohideenChief Medical Officer4 yr 7 mo8 callsCurrentSample
OTHER_C_SUITE since 2021 • 11/20 beats (55%) • last guidance raise Q1 FY2026
- Sebastien RobitailleCFO1 yrno recorded callsFormerSample
CFO since 2021 • 8/20 beats (40%) • last guidance raise Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for DBVT.
$ curl https://api.spokenalpha.com/v1/companies/DBVTFAQ
Frequently asked about DBVT
Where can I find DBV Technologies S.A.'s (DBVT) earnings call transcripts?
Spoken Alpha indexes DBVT's earnings call transcripts at https://spokenalpha.com/companies/DBVT. Each call links to attributed speakers and parsed analyst Q&A.
What sector is DBVT in?
DBV Technologies S.A. (DBVT) operates in the Healthcare sector (Biotechnology industry).